BACKGROUND:Ergothioneine (ET) is a sulfur containing amino acid that functions as an antioxidant. Mushrooms are a primary source of ET containing from 0.4 to 2.0mg/g (dry-weight). The bioavailability of ET from mushrooms in humans remains unclear. OBJECTIVE: We evaluated the bioavailability of ET in healthy men (n=10) in a pilot study, using a randomized, cross-over, dose-response, postprandial time-course design, conducted at the General Clinical Research Center at Pennsylvania State University in 2009. METHOD: ET was administered through a mushroom test meal containing 8 g and 16 g of mushroom powder. Postprandial red blood cell concentrations of ET were measured. Plasma glucose, triglycerides, HDL, LDL and total cholesterol also were monitored. Biomarkers of inflammation and oxidative stress were evaluated using C-reactive protein and ORAC(total). RESULTS: ET was bioavailable after consuming mushrooms and a trend in the postprandial triglyceride response indicated that there was a blunting effect after both the 8 g and 16 g ET doses were compared with the 0 g dose. Despite ET's antioxidant properties, ORAC(total) values decreased after the 8 g and 16 g mushroom meal. CONCLUSIONS: Ergothioneine from A. bisporus mushrooms is bioavailable as assessed by red blood cell uptake postprandially, and consumption is associated with an attenuated postprandial TG response.
RCT Entities:
BACKGROUND:Ergothioneine (ET) is a sulfur containing amino acid that functions as an antioxidant. Mushrooms are a primary source of ET containing from 0.4 to 2.0mg/g (dry-weight). The bioavailability of ET from mushrooms in humans remains unclear. OBJECTIVE: We evaluated the bioavailability of ET in healthy men (n=10) in a pilot study, using a randomized, cross-over, dose-response, postprandial time-course design, conducted at the General Clinical Research Center at Pennsylvania State University in 2009. METHOD:ET was administered through a mushroom test meal containing 8 g and 16 g of mushroom powder. Postprandial red blood cell concentrations of ET were measured. Plasma glucose, triglycerides, HDL, LDL and total cholesterol also were monitored. Biomarkers of inflammation and oxidative stress were evaluated using C-reactive protein and ORAC(total). RESULTS:ET was bioavailable after consuming mushrooms and a trend in the postprandial triglyceride response indicated that there was a blunting effect after both the 8 g and 16 g ET doses were compared with the 0 g dose. Despite ET's antioxidant properties, ORAC(total) values decreased after the 8 g and 16 g mushroom meal. CONCLUSIONS:Ergothioneine from A. bisporusmushrooms is bioavailable as assessed by red blood cell uptake postprandially, and consumption is associated with an attenuated postprandial TG response.
Authors: Mary Jo Feeney; Johanna Dwyer; Clare M Hasler-Lewis; John A Milner; Manny Noakes; Sylvia Rowe; Mark Wach; Robert B Beelman; Joe Caldwell; Margherita T Cantorna; Lisa A Castlebury; Shu-Ting Chang; Lawrence J Cheskin; Roger Clemens; Greg Drescher; Victor L Fulgoni; David B Haytowitz; Van S Hubbard; David Law; Amy Myrdal Miller; Bart Minor; Susan S Percival; Gabriela Riscuta; Barbara Schneeman; Suzanne Thornsbury; Cheryl D Toner; Catherine E Woteki; Dayong Wu Journal: J Nutr Date: 2014-05-08 Impact factor: 4.798
Authors: Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell Journal: Nutr Res Rev Date: 2020-02-13 Impact factor: 7.800
Authors: Djibril M Ba; Paddy Ssentongo; Robert B Beelman; Joshua Muscat; Xiang Gao; John P Richie Journal: Adv Nutr Date: 2021-10-01 Impact factor: 8.701